S gene mutation of blood donors with occult hepatitis B virus infection in Huzhou area / 中国输血杂志

【Objective】 To analyze the characteristics of gene mutation in S region of blood donors with occult hepatitis B virus infection (OBI) in Huzhou area. 【Methods】 A total of 60 107 blood samples in Huzhou between October 2018 and June 2020 were collected by our blood station. Among them, 52 samples were NAT, yield and their epidemiological characteristics were analyzed. Twenty-seven OBI out of the 52 NAT yield samples were included in experimental group. Other eight HBV-infected individuals with positive HBsAg, core antibody (anti-HBc) and HBV-DNA were selected as positive control. Liver function and 5 serological markers of HBV were compared between the two groups, and HBV genotypes and amino acid mutation in S region in the two groups were analyzed. 【Results】 The number of NAT-yield samples were different by gender, age, and educational background (P0.05). Surface antigen (HBsAg) in the experimental group was significantly lower than that in the control group, while surface antibody (anti-HBs) and e antibody (anti-HBe) were significantly higher than those in the control group (P<0.05). Twenty sequences in S region were obtained from the experimental group, including 4 in S region and 16 in preSS region; 16 cases with type C and 4 cases with type B. 【Conclusion】 The follow-up of NAT-yield blood donors in Huzhou area should be conducted. Compared with HBV infected individuals with positive HBsAg, anti-HBc and HBV-DNA, those with OBI have a higher gene mutation rate in S region.

Prevalence of occult HBV infection among blood donors in Huzhou City，Zhejiang Province / 上海预防医学

Objective To explore the prevalence and characteristics of occult hepatitis B virus infection （OBI） among blood donors in Huzhou region. Methods A total of 31 348 blood donors collected from October 2018 to February 2020 were selected for detecting HBV infection markers by serological and nucleic acid detection techniques. According to the detection results， 27 cases of HBsAg double negative （two kinds of reagent detection）， nucleic acid amplification technology （NAT） positive samples were identified as the occult HBV infection group （OBI group）； 25 cases of HBsAg double positive （two kinds of reagent detection）， NAT positive samples were identified as dominant HBV infection group， respectively. HBV nucleic acid quantitative detection， serum hepatitis B three line markers， liver function markers detection， and the results of the two groups were compared and analyzed. Results There were 31 034 HBsAg negative blood donors， 27 of whom were HBV-DNA positive， and the prevalence of OBI was 0.87 ‰. Six kinds of serology were found in 27 OBI patients， among which 25 cases （92.6%） were HBcAb， 17 cases （63.0%） were HBsAb， 17 cases （63.0%） were HBeAb， 15 cases （55.6%） were HBcAb and HBsAb， and 14 cases （51.9%） were HBcAb and HBeAb. There was no significant difference in gender， HBcAb positive rate， TBI， AST and ALT between the two groups （ P >0.05）. There were significant differences in age and HBsAb level （ χ 2=1.201， P <0.001； t =28.336， P <0.001）， and the average viral load was （25.86±19.68） IU/mL， which was significantly lower than the average viral load of the control group （3 254.65±535.98）IU/mL（ t =32.412， P <0.01）. Conclusion There is a certain prevalence of OBI in blood donors in Huzhou area. The main kinds of serology are HBcAb and HBsAb. Serological detection combined with nucleic acid detection can ensure the safety of blood transfusion and reduce the risk of blood borne diseases.

Prevalence of occult HBV infection among blood donors in Huzhou City，Zhejiang Province / 上海预防医学

Objective To explore the prevalence and characteristics of occult hepatitis B virus infection （OBI） among blood donors in Huzhou region. Methods A total of 31 348 blood donors collected from October 2018 to February 2020 were selected for detecting HBV infection markers by serological and nucleic acid detection techniques. According to the detection results， 27 cases of HBsAg double negative （two kinds of reagent detection）， nucleic acid amplification technology （NAT） positive samples were identified as the occult HBV infection group （OBI group）； 25 cases of HBsAg double positive （two kinds of reagent detection）， NAT positive samples were identified as dominant HBV infection group， respectively. HBV nucleic acid quantitative detection， serum hepatitis B three line markers， liver function markers detection， and the results of the two groups were compared and analyzed. Results There were 31 034 HBsAg negative blood donors， 27 of whom were HBV-DNA positive， and the prevalence of OBI was 0.87 ‰. Six kinds of serology were found in 27 OBI patients， among which 25 cases （92.6%） were HBcAb， 17 cases （63.0%） were HBsAb， 17 cases （63.0%） were HBeAb， 15 cases （55.6%） were HBcAb and HBsAb， and 14 cases （51.9%） were HBcAb and HBeAb. There was no significant difference in gender， HBcAb positive rate， TBI， AST and ALT between the two groups （ P >0.05）. There were significant differences in age and HBsAb level （ χ 2=1.201， P <0.001； t =28.336， P <0.001）， and the average viral load was （25.86±19.68） IU/mL， which was significantly lower than the average viral load of the control group （3 254.65±535.98）IU/mL（ t =32.412， P <0.01）. Conclusion There is a certain prevalence of OBI in blood donors in Huzhou area. The main kinds of serology are HBcAb and HBsAb. Serological detection combined with nucleic acid detection can ensure the safety of blood transfusion and reduce the risk of blood borne diseases.

Occult hepatitis B virus load and molecular mutation in blood donors, Huzhou / 中国输血杂志

【Objective】 To investigate the prevalence of occult hepatitis B virus infection (OBI) among blood donors in Huzhou, and to analyze the viral load and molecular characteristics of OBI. 【Methods】 45 368 blood samples were screened by enzyme linked immunosorbent assay (ELISA) and nucleic acid testing (NAT) for HBV infection from October 2018 to February 2020 in our center. HBsAg-/NAT+ blood donors were studied as experimental group, contemporary HBsAg+ /NAT+ donors as the control. The serum viral nucleic acids of the two groups were extracted, and HBV DNA copies were detected by real-time PCR, the differences between the two groups were compared. The S region gene of the virus was amplified and sequenced by Nested PCR, then compared with the reference sequence of HBV wild type, in order to confirm the genotyping and molecular mutation characteristics of S region. 【Results】 36 samples were confirmed as OBI (0.08%, 36 / 45 368). The HBV DNA load of 8 samples was lower than the detection limit, and the average HBV DNA load of other 28 samples was (42.3±1.24) IU / mL, which was significantly lower than that of the controls (3.32±1.94) ×104 IU / mL(P<0.05). Among the 28 OBI samples, 20 were type B (71.43%), and 8 were type C (28.57%). The frequency of amino acid variation in HBsAg epitopes was significantly higher in OBI than in MHR(P<0.05). 【Conclusion】 The viral load of OBI blood donors in Huzhou, mainly genotype B, is low, and the variation sites were mainly focused in HBsAg epitope and amino acid region (124~147).

Antibodies identification and crossmatching of a case with alloanti-C, e combing autoantibody mimicking alloanti-e / 中国输血杂志

Objective To understand the difference of serological characteristic between alloantibodies,'simple'Rhspecific autoantibodies and autoantibodies mimicking alloantibodies by studies of a patient who produces alloantibodies and autoantibodies that to distinguish Serologically them in order to more appropriate RBC component transfusion administration would be performed for patients.Methods Several serological methods were performed to the patient's serum samples for identification of antibodies by using two antibody screening cell reagents from different manufacturers.Using adsorption of the patient's Rh antibodies in the presence of LISS with the antibody was similar to that of the antigen negative cell from a donor who had a ccDEE Rh type and O type,and to detect antibodies in the absorbed serum and the eluting solution.Results The patient had a ccDEE Rh type with a positive direct antiglobulin test (DAT).Serum antibodies were identified as IgM anti-C,anti-e and IgG anti-e;the possibility of anti-Ce antibody is not excluded.After absorption,serum antibodies were identified as IgM anti-C,anti-e and IgG anti-e;anti-Ce antibody is not excluded.The antibody in patient's RBC elution was identified as IgG anti-e antibody.Conclusion Alloantibody and mimicking alloantibody can be distinguished by comprehensive analysis of patient's Rh phenotype,DAT result and antibody specificity in the serum and absorbed serum and elution of RBC.The low affinity antibody can be better absorbed by adding low ionic liquid (LISS).

The significance of serum xanthine oxidoreductase in patients with type 2 diabetes / 中华内分泌外科杂志

Objective Increased serum uric acid level is associated with type 2 diabetes (T2DM) through the mechanism of oxidative stress.As the rate-limiting enzyme in the degradation of purines in humans,xanthine oxidoreductase (XOR)catalyzes the final two reactions of purine catabolism,oxidizing hypoxanthine to xanthine,and xanthine to uric acid.The aim of this study is to investigate the association between serum XOR activity and T2DM.Methods A total of 270 patients with T2DM and 140 age-and-gender-matched health controls were enrolled in the study.The clinical examinations such as weight and height were conducted in the morning after an overnight fast.Serum XOR activity and other biochemical parameters like triglyceride,total cholesterol,high density lipoprotein cholesterol,fasting plasma glucose and uric acid levels were measured.Results Serum XOR activity was significantly elevated in T2DM patients compared with that in the controls (31.2 ± 8.91 vs 4.6 ± 0.91 U/L,P ＜0.01).Serum XOR activity was significantly elevated in T2DM patients complicated with lower extremity arterial disease compared to that in patients without lower extremity arterial disease (42.1 ± 8.43 vs 23.7 ± 5.31 U/L,P ＜ 0.01).Conclusion High XOR activity plays an important role in onset and development of T2DM.